The Latest Information from the Front Lines on Current and Emerging Enforcement Hot Spots and Practical Compliance Strategies

About

The staggering TAP settlement of October 2001 was by no means the end of the story. Rather, it marked the beginning of a more aggressive enforcement era in the pharmaceutical and medical device arena.

With the dust barely settled from the TAP, Bayer and Pfizer settlements, more companies are under investigation for promotion practices and alleged pricing irregularities. Enforcers are employing innovative means to include companies in the ever-widening net of prosecution, from consumer fraud to conspiracy to defraud to false claims. The industry is facing significant pressure to implement, maintain and monitor effective, comprehensive and appropriate compliance strategies. It is clear that no pharmaceutical or device manufacturer will remain a leader without effective in-house compliance policies and a comprehensive understanding of current enforcement activity and allegations.

In this volatile arena, even the most sophisticated corporate counsel, sales and marketing executive and compliance officer needs an up-to-the minute understanding of the latest developments…and a forecast for what tomorrow's enforcement agenda holds. American Conference Institute's Third National Forum on Fraud and Abuse in the Sales and Marketing of Drugs and Medical Devices materials will provide you with a sophisticated and comprehensive overview of the most difficult, pressing and costly issues, including effective compliance - from the front lines.
The faculty included prosecutors in the most active jurisdictions who will provide timely and critical insight on current civil and criminal theories, how to avoid the microscope of enforcement and emerging trends.
In-house counsel from Pfizer, Pharmacia, Wyeth, Boehringer Ingelheim and Sanofi-Synthelabo also shared their experiences in creating and maintaining effective compliance strategies.

And that's not all! Along with the key prosecutors and in-house counsel, expert outside attorneys offered practical tips and insights on the hottest issues for today…and tomorrow, including:

Tactics from the trenches - the lessons of TAP and Bayer

Comprehensive overview of the latest enforcement
activity… and forecast for tomorrow

Contents & Contributors

About

The staggering TAP settlement of October 2001 was by no means the end of the story. Rather, it marked the beginning of a more aggressive enforcement era in the pharmaceutical and medical device arena.

With the dust barely settled from the TAP, Bayer and Pfizer settlements, more companies are under investigation for promotion practices and alleged pricing irregularities. Enforcers are employing innovative means to include companies in the ever-widening net of prosecution, from consumer fraud to conspiracy to defraud to false claims. The industry is facing significant pressure to implement, maintain and monitor effective, comprehensive and appropriate compliance strategies. It is clear that no pharmaceutical or device manufacturer will remain a leader without effective in-house compliance policies and a comprehensive understanding of current enforcement activity and allegations.

In this volatile arena, even the most sophisticated corporate counsel, sales and marketing executive and compliance officer needs an up-to-the minute understanding of the latest developments…and a forecast for what tomorrow's enforcement agenda holds. American Conference Institute's Third National Forum on Fraud and Abuse in the Sales and Marketing of Drugs and Medical Devices materials will provide you with a sophisticated and comprehensive overview of the most difficult, pressing and costly issues, including effective compliance - from the front lines.
The faculty included prosecutors in the most active jurisdictions who will provide timely and critical insight on current civil and criminal theories, how to avoid the microscope of enforcement and emerging trends.
In-house counsel from Pfizer, Pharmacia, Wyeth, Boehringer Ingelheim and Sanofi-Synthelabo also shared their experiences in creating and maintaining effective compliance strategies.

And that's not all! Along with the key prosecutors and in-house counsel, expert outside attorneys offered practical tips and insights on the hottest issues for today…and tomorrow, including:

Tactics from the trenches - the lessons of TAP and Bayer

Comprehensive overview of the latest enforcement
activity… and forecast for tomorrow